Shanghai Genomics was officially registered in August, 2001 with investment from two prestigious venture capital firms in China, Shanghai Venture Capital Company and Shanghai Zhangjiang Hi-Tech Park Corp. The registered total asset is 43 million RMB ( US$ 5.2 million )



>> GNI, Ltd.


   GNI Ltd. is an international pharmaceutical development group with campuses in Tokyo and Fukuoka, Japan, and Cambridge, U.K. GNI develops therapeutic pharmaceutical products internally and in collaboration with other pharmaceutical companies through gene regulatory networks and systems pharmacology techniques based on the gene regulatory network research at University of Cambridge (Cambridge, UK), Kyushu University and University of Tokyo in Japan. GNI's founders pioneered the use of gene regulatory network maps in microbes and in humans to identify effective pharmaceutical molecules in the genome. The aim of GNI is to develop new therapeutic/diagnostic products in the fields of infectious diseases, cardiovascular diseases, inflammation and cancer diagnosis.

website:http://www.gene-networks.com





>> Shanghai Venture Capital Company


   Established in August 1999, Shanghai Venture Capital Co. Ltd. serves as a sole investment manager of 600 million RMB from Shanghai Municipal Government and is specialized in high-tech investment. In two years, SHVC has invested in 93 portfolio projects in four major fields, including IT, Biotechnology, new materials, and upgrading traditional manufacturing industry by applying new high technologies. The central purpose of SHVC is, via adoption of commonly in use international conventions associated with professional financial management, to entrust various venture capitalists to assist small startup firms and entrepreneurs in traversing the competitive rigors of the market, helping them to achieve success.

website:http://www.shvc.com.cn



>> Shanghai Zhangjiang Hi-Tech Park Development Corporate

  Shanghai Zhangjiang Hi-Tech Park Development Corp. is a listed company in Shanghai Stock Exchange ( stock code 600895 ). Established on April 18, 1996, it is mainly engaged in property development and investment of technology projects and operations planted in Shanghai Pudong - Zhangjiang Hi-Tech Park. Its total asset amounted to over 3 billion RMB at the end of year 2002.

website:http://www.600895.com



 
 
© 2008 shanghaigenomics.com. All rights reserved